Immunomodulators Market Hits USD 233.7 Billion By 2025: Grand View Research, Inc.

The global immunomodulators market is expected to reach USD 233.7 billion by 2025, according to a new study by Grand View Research, Inc. The market is anticipated to be predominantly driven by high R&D investments employed by the prominent companies, resulting into the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs at an unprecedented rate into the immunomodulators market hence providing highly efficacious treatment alternatives for numerous autoimmune and inflammatory diseases.

In addition, increasing drugs resistance is predicted to be responsible for boosting the clinical urgency to develop potentially new generation immunomodulators with targeted therapy mechanisms. The aforementioned factors cumulatively are expected to present significant growth opportunities over the forecast period.

Furthermore,burgeoning presence of the key players is expected to promote the awareness levels pertaining to benefits of immunomodulators amongst the patients as well as the physicians. This is further expected to widen the immunomodulators industry growth potential during the forecast period.

In addition, increasing adoption of monoclonal antibodies for a wide range of indications, such as, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and Non-Hodgkin’s Lymphoma, which is expected to boost immunomodulators industry over the forecast period. The consistent number of product approvals of highly significant monoclonal antibodies in autoimmune diseases is predicted to be responsible for widening the scope of growth.

 Browse full research report on Global Immunomodulators market: http://www.grandviewresearch.com/industry-analysis/immunomodulators-market

Further Key Findings From the Study Suggest:
  • Immunosuppressant held the largest share of the product segment in 2015, owing to increasing number of transplantation procedures and need to prevent organ rejection
  • Antibodies held the dominant share of immunosuppressant in 2015, owing to extensive utilization in kidney, liver, heart, and lung transplants resulting in greater revenue generation
  • Immunostimulants expected to grow lucratively as a result of lower influx of immunostimulant generics for application in HIV, cancer and multiple sclerosis
  • In 2015, North America dominated the global immunomodulators market owing to presence of wide number of established pharmaceutical companies involved in extensive commercialization
  • The prominent participants are undertaking research and clinical collaborative strategies to yield new drugs and thereby to gain competitive advantage
  • For instance, in March 2015, Novartis AG entered into research collaboration with Aduro Biotech. This was carried out to enhance its next generation cancer immunotherapy product pipeline
 Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the immunomodulators market on the basis of product, application, and region:
  • Global Product Outlook (Revenue, USD Billion, 2014 - 2025)
    • Immunosuppressant
      • Antibodies
      • Calcineurin inhibitors
      • Glucocorticoids
      • Antimetabolites
      • Others
    • Immunostimulants
      • Vaccines
      • Antibodies
      • Others
  • Global Application Outlook (Revenue, USD Billion, 2014 - 2025)
    • Oncology
    • Respiratory
    • HIV
    • Others
  • Regional Outlook (Revenue, USD Billion, 2014 - 2025)
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Mexico
      • Brazil
    • MEA
      • South Africa
 Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-immunomodulators-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Small Animal Imaging Market To Be Driven By Increasing The Number Of Pharmaceutical & Research Organizations Till 2022:Grand View Research,inc.

Global  Small Animal Imaging (In-Vivo) market   is expected to reach USD 2.7 billion by 2022, according to a new study by Grand View Research, Inc. Growing number of medical conditions requiring accurate research for development of treatment options is expected to enhance demand for small animal imaging (in-Vivo) over the forecast period. Importance of these devices in applications such as epigenetic research studies, drug receptor targeting, and defining mechanism of action is estimated to provide potential growth platform for this industry.  The major factors driving the growth of small animal imaging (in-vivo) market are growing usage of multi-functional pre-clinical imaging, rising investments of CROs in pre-clinical studies, increasing number of pharmaceutical and research organizations and technical innovations such as high-resolution MRI with other modalities. Browse full research report on Small Animal Imaging Market: http://www.grandviewresearch.c...
Read more

Waste To Energy Market Is Projected To Witness Growth Based On Increasing Demand For Renewable Sources Till 2024:Grand View Research,inc.

The global  waste to energy (WTE) market  is expected to reach USD 43.96 billion by 2024, according to a new report by Grand View Research, Inc. Stringent waste management regulations particularly in Europe and in the U.S. coupled with the rise in concern to improve the waste management systems is expected to remain a key driving factor for global waste to energy market. The shift in focus towards energy generation through alternative routes is also expected to shape the industry structure.  Emerging economies such as India and China has been witnessing a sharp increase in energy demand on account of rapid industrialization and urbanization which has prompted energy producers to look for alternative energy sources. Since these countries generate a lot of industrial waste, they have become high potential markets for WTE technologies and are expected to provide ample opportunities to companies involved.  Companies such as China Everbright International Ltd. a...
Read more

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics es...
Read more